EPISODE 144
In this interview, Murthy Simhambhatla, president and CEO of SetPoint Medical, explains why he moved into the Medtech industry and how that path has positioned him to lead SetPoint Medical, one of the industry’s most promising start-ups.
Podcast Guest
Murthy Simhambhatla
President and CEO
SetPoint Medical
Murthy Simhambhatla was formerly the President and Chief Executive Officer of Evolus, a medical aesthetics company with a lead biologic drug, DWP-450, which he led towards an IPO in 2018. Prior to Evolus, Dr. Simhambhatla was a Senior Vice President at Abbott Laboratories and President of Abbott Medical Optics, a $1B-plus global ophthalmic business focused on cataract and refractive surgery.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.
